Please assess the completion status of the following clinical trial:

Trial Title: Study of Patients With Metastatic and/or Advanced Renal Cell Carcinoma, Treated With Sunitinib/Axitinib.

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: RETROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion criteria~1. Over the age of 18 years~2. Diagnosis of renal cell carcinoma~3. Treatment with sunitinib and/or axitinib~4. Timeframe: from database inception date (2002) until June 30, 2018.~Exclusion criteria~Patients meeting any of the following criteria will not be included in the study:~1. Under the age of 18 years~2. Diagnosis other than renal cell carcinoma~3. No treatment with sunitinib and/or axitinib

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Patients with advanced RCC (Type: None): Patients with a diagnosis of kidney cancer (renal cell carcinoma, advanced or metastatic)

Based on this trial design, predict the completion outcome and termination type (if applicable).